Genetically engineered grains are mainstream, but gene splicing in livestock remains experimental. A Boston area biotechnology firm hopes to change that and end its 18-year quest for commercial approval.
Growth in emerging markets is driving activity, despite the need for manufacturers to tackle economic challenges, cut costs, ensure operational efficiency and decrease environmental impact.
The casual use of antibiotics on farms leads to antibiotic residue in the meat consumed by humans, decreasing the efficacy of antibiotics when they’re actually needed and causing allergic reactions in some people.